Self-expandable metal stents are a valid option in long-term survivors of advanced esophageal cancer

Rodrigues‐Pinto, Eduardo; Pereira, Pedro; Baron, Todd H.; Macedo, Guilherme

doi:10.17235/reed.2018.5323/2017

Cited by 5 publications

(4 citation statements)

References 24 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Re-obstruction due to ingrowth ranges between 17 and 36% for uncovered stents and is uncommon for covered stents [ 2 , 3 , 16 ]. Adverse events, including tumour overgrowth, may occur in up to 60% of the patients who are followed up for long periods [ 3 , 31 ].…”

Section: Oesophageal Stentingmentioning

confidence: 99%

CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting

Diamantopoulos

Choudhury

Irani

et al. 2023

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Background Image-guided insertion of stents in the upper gastrointestinal trunk is an effective, minimally invasive treatment option to provide immediate relief of symptoms caused by upper gastrointestinal tract obstruction related to advanced-stage malignant causes or benign causes that lead to lumen narrowing. Purpose This document, as with all CIRSE Standards of Practice documents, is not intended to impose a standard of clinical patient care but will recommend a reasonable approach to best practices for performing stenting of the upper gastrointestinal tract, namely the oesophageal and gastroduodenal segments. Our purpose is to provide up-to-date recommendations for placement of upper gastrointestinal tract stents based on the previously published guidelines on this topic in 2005 and 2007. Methods The writing group was established by the CIRSE Standards of Practice Committee and consisted of a group of internationally recognised experts in performing upper gastrointestinal stenting. The writing group reviewed the existing literature using PubMed to search for relevant publications in the English language up to September 2021. The final recommendations were formulated through consensus. Conclusion Insertion of stents in the oesophageal and gastroduodenal tracts has an established role in the successful management of malignant or benign obstructions. This Standards of Practice document provides up-to-date recommendations for the safe performance of upper gastrointestinal stent placement.

show abstract

Section: Oesophageal Stentingmentioning

confidence: 99%

CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting

Diamantopoulos

Choudhury

Irani

et al. 2023

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

show abstract

“…Stent placement into the esophagus has been used widely because of its rapid improvement of dysphagia, and is the most common treatment for NEAS ( 1 , 29 ). Pinto and colleagues ( 30 ) reported that in the palliative treatment of patients with advanced esophageal cancer, the patency duration of an esophageal stent in 42 patients was 236 days, and that the clinical symptoms of all patients were improved. However, implantation of a simple stent into the esophagus only temporarily solves the problem of an esophagogastric anastomotic stricture and does not treat the primary disease.…”

Section: Discussionmentioning

confidence: 99%

Arterial Infusion Chemotherapy for Neoplastic Esophagogastric Anastomotic Strictures After Esophagectomy

Xie

Yin

et al. 2021

Front. Oncol.

View full text Add to dashboard Cite

BackgroundNeoplastic esophagogastric anastomotic strictures after resection of esophageal cancer is a very difficult problem in clinical practice. We aim at to investigate the safety and feasibility of arterial infusion chemotherapy in treatment of neoplastic esophagogastric anastomotic strictures after esophagectomy.MethodsFrom October 2014 to December 2019, 50 patients with Neoplastic esophagogastric anastomotic strictures after resection of esophageal cancer were assessed retrospectively. Preoperative dysphagia was grade III in 34 cases and grade IV in 16 cases. Thirty-eight patients had different degrees of dyspnea before surgery Twenty-five patients had intolerable (grade IV) dyspnea and airway stenting was undertaken before surgery. Thirteen patients had tolerable dyspnea that did not require airway stenting, and preoperative dyspnea was grade III.ResultsAll patients were successfully treated with arterial infusion chemotherapy, no paraplegia or death occurred. The dysphagia grade of 50 patients after AIC was compared: one case had grade I, 40 cases had grade II, and nine cases had grade III. Thirteen patients had tolerable dyspnea that did not necessitate airway stenting. Dyspnea was classified as grade I in five cases and grade II in eight cases. After 1–3 courses of AIC, 50 patients were followed up for a complete response (eight cases), partial response (28) and stable disease (14 cases). Total objective effective rate (complete response+ partial response) and disease control rate(complete response + partial response + stable disease)were 72.0% and 100.0%, respectively. The median duration of follow-up was 8.5 months. One-year survival was 46.0%.ConclusionArterial infusion chemotherapy is safe and efficacious treatment for Neoplastic esophagogastric anastomotic strictures after esophagectomy.

show abstract

“…Some retrospective cohorts evaluated patients submitted to SEMS placement, with ≥6-month survival, and concluded that SEMS may be a valid alternative, especially in centers where brachytherapy is not widely available. Despite the increased risk of AEs over time, most of them can be managed endoscopically [ 20 , 21 , 22 ].…”

Section: Esophageal Stentingmentioning

confidence: 99%

“…GE Port J Gastroenterol 2023;30(suppl 1):[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] …”

unclassified

Best Practices in Esophageal, Gastroduodenal, and Colonic Stenting

Medas

Ferreira‐Silva

Girotra

et al. 2022

GE Port J Gastroenterol

Self Cite

View full text Add to dashboard Cite

Endoscopic stenting is an area of endoscopy that has witnessed noteworthy advancements over the last decade, resulting in evolving clinical practices among gastroenterologists around the world. Indications for endoscopic stenting have progressively expanded, becoming a frequent part of the management algorithm for various benign and malignant conditions of the gastrointestinal tract, from esophagus to rectum. In addition to expanded indications, continuous technological enhancements and development of novel endoscopic stents have resulted in an increased success of these approaches and, in some cases, allowed new applications. This review aimed to summarize best practices in esophageal, gastroduodenal, and colonic stenting.

show abstract

Self-expandable metal stents are a valid option in long-term survivors of advanced esophageal cancer

Cited by 5 publications

References 24 publications

CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting

CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting

Arterial Infusion Chemotherapy for Neoplastic Esophagogastric Anastomotic Strictures After Esophagectomy

Best Practices in Esophageal, Gastroduodenal, and Colonic Stenting

Contact Info

Product

Resources

About